Provided by Tiger Trade Technology Pte. Ltd.

Entera Bio Ltd.

3.44
+0.02000.58%
Volume:323.62K
Turnover:1.12M
Market Cap:595.12M
PE:-9.73
High:3.56
Open:3.42
Low:3.41
Close:3.42
52wk High:4.20
52wk Low:0.9100
Shares:173.00M
Float Shares:138.87M
Volume Ratio:0.83
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3536
EPS(LYR):-0.2476
ROE:-138.92%
ROA:-45.98%
PB:81.90
PE(LYR):-13.89

Loading ...

Entera Bio prices $10 million private placement led by BVF Partners

Reuters
·
Apr 07

Entera Bio prices USD 10 million private placement led by BVF Partners

Reuters
·
Apr 02

Stock Market Today: S&P 500, Dow Futures Gain As Trump Calls Iran's New Leaders 'Very Reasonable'—Palantir, Rezolve AI, Entera Bio In Focus

Benzinga_recent_news
·
Mar 30

Phreesia, Progress Software And 3 Stocks To Watch Heading Into Monday

Benzinga Earnings
·
Mar 30

Entera Bio Q4 EPS $(0.06) Beats $(0.09) Estimate

Benzinga Earnings
·
Mar 28

Entera Bio FY2025 operating expenses rise 19.79% to $12 million; net loss widens to $11 million on no revenue

Reuters
·
Mar 28

Press Release: Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates

Dow Jones
·
Mar 28

Entera Bio Ltd expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
Mar 25

Entera Bio Director Geno J Germano Acquires Entera Bio Common Shares

Reuters
·
Mar 11

Entera Bio Moves Toward Phase 3 With Oral Therapy That Could Transform Osteoporosis Treatment (NASDAQ: ENTX)

TIPRANKS
·
Mar 05

Entera Bio Submits Streamlined Phase 3 Protocol To Initiate Registrational Program For Eb613 In Postmenopausal Women With Osteoporosis

Reuters
·
Mar 04

Entera Bio Submits Streamlined EB613 Phase 3 Protocol Amendment to FDA

Reuters
·
Mar 04

Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis

GlobeNewswire
·
Mar 04

Entera Bio CEO Miranda Toledano to Join Fireside Chat at Leerink Partners Global Healthcare Conference 2026

Reuters
·
Feb 26